Transplantation may be more effective than tumor resection as initial surgery for some patients with chemotherapy-sensitive hepatoblastomas, according to a report presented at the annual meeting of the American Association for the Study of Liver Diseases by researchers at Birmingham Children's Hospital in the UK.
today announced that supportive data from a preclinical study of the Company's lead product candidate for hepatitis C (HCV), SCY-635, will be presented in a poster session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) being held in Boston, MA, October 30-November 3, 2009.
Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 30 - June 4, 2009, at the McCormick Place, Chicago, IL.
Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases SAN DIEGO -- Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported positive additional interim results from its ongoing phase I/II clinical study of its therapeutic DNA vaccine against hepatitis C virus (HCV).
today announced that data from preclinical studies of the Company's lead product candidate for hepatitis C (HCV), SCY-635, will be presented in poster sessions at the 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) being held in San Francisco, October 31-November 4, 2008.
BOSTON -- New clinical data on the hepatitis C polymerase inhibitor R1626 - currently in development by Roche - show viral reductions greater than those described for other polymerase inhibitors, according to data presented at the 57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).